NTRK, RET, BRAF, and ALK fusions in thyroid fine-needle aspirates (FNAs).
2021
6083Background: Receptor tyrosine kinase (RTK) fusions may be targeted by small molecule inhibitors to treat various advanced tumors, including thyroid cancer. Clinical trials have studied selectiv...
Keywords:
-
Correction
-
Source
-
Cite
-
Save
0
References
0
Citations
NaN
KQI